IL4 and osteoarthritis: A fusion protein of interleukin-4 and interleukin-10 (IL4-10 FP) wasdeveloped as a disease-modifying osteoarthritis drug (DMOAD), andchondroprotection, anti-inflammation, and analgesia have been suggested.